Literature DB >> 17979856

Bimanual training for children with unilateral CP - is this something new?

Ann-Christin Eliasson.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17979856     DOI: 10.1111/j.1469-8749.2007.00806.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  4 in total

1.  Does Corticospinal Tract Connectivity Influence the Response to Intensive Bimanual Therapy in Children With Unilateral Cerebral Palsy?

Authors:  Ana R P Smorenburg; Andrew M Gordon; Hsing-Ching Kuo; Claudio L Ferre; Marina Brandao; Yannick Bleyenheuft; Jason B Carmel; Kathleen M Friel
Journal:  Neurorehabil Neural Repair       Date:  2016-11-17       Impact factor: 3.919

2.  Modified constraint-induced movement therapy or bimanual occupational therapy following injection of Botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper.

Authors:  Brian J Hoare; Christine Imms; Hyam Barry Rawicki; Leeanne Carey
Journal:  BMC Neurol       Date:  2010-07-05       Impact factor: 2.474

3.  REACH: study protocol of a randomised trial of rehabilitation very early in congenital hemiplegia.

Authors:  Roslyn N Boyd; Jenny Ziviani; Leanne Sakzewski; Iona Novak; Nadia Badawi; Kerstin Pannek; Catherine Elliott; Susan Greaves; Andrea Guzzetta; Koa Whittingham; Jane Valentine; Cathy Morgan; Margaret Wallen; Ann-Christin Eliasson; Lisa Findlay; Robert Ware; Simona Fiori; Stephen Rose
Journal:  BMJ Open       Date:  2017-09-18       Impact factor: 2.692

4.  INCITE: A randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia.

Authors:  Roslyn Boyd; Leanne Sakzewski; Jenny Ziviani; David F Abbott; Radwa Badawy; Rose Gilmore; Kerry Provan; Jacques-Donald Tournier; Richard A L Macdonell; Graeme D Jackson
Journal:  BMC Neurol       Date:  2010-01-12       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.